Multi-sample protein–protein interplay evaluation and visualization instrument
We posit the possible structure of advanced ailments is that subgroups of sufferers share variants in genes in particular networks that are enough to offer rise to a shared phenotype. We developed Proteinarium, a multi-sample protein-protein interplay (PPI) instrument, to establish clusters of sufferers with shared gene networks.
Proteinarium converts person outlined seed genes to protein symbols and maps them onto the STRING interactome. A PPI community is constructed for every pattern utilizing Dijkstra’s algorithm. Pairwise similarity scores are calculated to check the networks and cluster the samples.
A layered graph of PPI networks for the samples in any cluster might be visualized. To check this newly developed evaluation pipeline, we reanalyzed publicly out there information units, from which modest outcomes had beforehand been achieved.
We discovered important clusters of sufferers with distinctive genes which enhanced the findings within the unique research.
rbprotein
Linking TPPII to the protein interplay and signalling networks
Tripeptidyl peptidase II (TPPII) is primarily thought-about a house-keeping exopeptidase, which contributes to the features of the ubiquitin-proteasome system by the upkeep of the mobile amino acid homeostasis.
Though functionally well-characterised in vitro and utilizing the mammalian cell fashions, much less is thought in regards to the molecular mechanisms of its involvement within the signaling and metabolic pathways, which mediate its mobile features.
The current protein-protein interplay community evaluation recognized these mechanisms concerned within the adaptive and innate immunity, the metabolism of the glucose, most cancers cell development, apoptosis, cell cycle and DNA injury responses.
The interplay community constructed primarily based on the publicly out there protein-protein interplay information was prolonged by the utility GeneMania, which was additional used for the pathway enrichment, the protein operate prediction and the protein node prioritisation evaluation.
Anti-Alpha Fetoprotein antibody
The evaluation prompt that the molecular mechanisms linked to the adaptive and innate immunity (ID, Package receptor, BCR, IL-2 and G-CSF signalling; the regulation of NFκB), the cardio glycolysis (ID and IL-2 signalling), tumorigenesis (TGF-β and p53 signalling; the highest precedence nodes MAPKs, mTOR regulation), diabetes (Package receptor signalling; the highest precedence node GSK3β) and neurodegeneration (the management of mTOR and Aβ peptide degradation) are controlling the ensuing TPPII interplay community.
The uncharacterized interactions with two lung most cancers suppressors (DOK3, DENND2D), a protein concerned within the elevated danger of the lung most cancers in people who smoke (CYP1A1) and a protein implicated in asthmatic reactions (CHIA) recommend potential roles of TPPII within the lung most cancers pathology.
The interactions with methyltransferase CARNMT1, which modifies di- and tripeptides and the xenobiotic processing enzyme CYP1A1, are further candidates for the breakthrough in new features discovery of TPPII.
Description: A sandwich ELISA for quantitative measurement of Human Alpha fetoprotein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich ELISA for quantitative measurement of Human Alpha fetoprotein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A sandwich ELISA for quantitative measurement of Human Alpha fetoprotein in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L1 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L2 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Description: A competitive ELISA for quantitative measurement of Human Alpha fetoprotein L3 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.
Mouse Anti Human Alpha Fetoprotein Monoclonal Antibody
Description: AFP alpha 1 Fetoprotein is a protein encoded by the AFP gene which is approximately 68,6 kDa. AFP alpha 1 Fetoprotein is secreted into the extra cellular space. It is involved in hippo signalling pathway, embryonic stem cell differentiation pathways and FOXA2 and FOXA3 transcription factor networks. It is a major plasma protein produced by the yolk sac and the liver during fetal life. In adults, alpha-fetoprotein expression is often associated with hepatoma or teratoma and is thought to be the fetal counterpart of serum albumin. AFP alpha 1 Fetoprotein is expressed in the heart, liver, cells of the nervous system, lung and blood. Mutations in the AFP gene may result in an alpha-fetoprotein deficiency. STJ96977 was developed from clone 17C5 and was affinity-purified from mouse ascites by affinity-chromatography using specific immunogen. This antibody detects endogenous AFP proteins.
Description: Alpha-fetoprotein is a major plasma protein produced by the yolk sac and the liver during fetal life. This protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4.
Description: Alpha-fetoprotein (AFP) is a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly.
Description: This gene encodes alpha-fetoprotein, a major plasma protein produced by the yolk sac and the liver during fetal life. Alpha-fetoprotein expression in adults is often associated with hepatoma or teratoma. However, hereditary persistance of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the alpha-fetoprotein and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. Alpha-fetoprotein is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of alpha-fetoprotein in amniotic fluid is used to measure renal loss of protein to screen for spina bifida and anencephaly. [RefSeq]
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. The yolk sac and the liver produce AFP during fetal life. AFP expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the AFP and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. AFP is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of AFP in amniotic fluid is used to measure renal loss of protein to screen for spinal bifida and anencephaly.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. The yolk sac and the liver produce AFP during fetal life. AFP expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the AFP and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. AFP is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of AFP in amniotic fluid is used to measure renal loss of protein to screen for spinal bifida and anencephaly.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. The yolk sac and the liver produce AFP during fetal life. AFP expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the AFP and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. AFP is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of AFP in amniotic fluid is used to measure renal loss of protein to screen for spinal bifida and anencephaly.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. The yolk sac and the liver produce AFP during fetal life. AFP expression in adults is often associated with hepatoma or teratoma. However, hereditary persistence of alpha-fetoprotein may also be found in individuals with no obvious pathology. The protein is thought to be the fetal counterpart of serum albumin, and the AFP and albumin genes are present in tandem in the same transcriptional orientation on chromosome 4. AFP is found in monomeric as well as dimeric and trimeric forms, and binds copper, nickel, fatty acids and bilirubin. The level of AFP in amniotic fluid is used to measure renal loss of protein to screen for spinal bifida and anencephaly.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP) (ISOBM TD-2 workshop). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP) (ISOBM TD-2 workshop). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP) (ISOBM TD-2 workshop). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: It recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as alpha fetoprotein (AFP) (ISOBM TD-2 workshop). This mAb is highly specific to AFP and shows no cross-reaction with other oncofetal antigens or serum albumin. AFP is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. Antibody to AFP has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: This antibody recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as Alpha fetoprotein (AFP). The AFP antibody is highly specific and shows no cross-reaction with other oncofetal antigens or serum albumin. Alpha fetoprotein is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. AFP antibody has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: This antibody recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as Alpha fetoprotein (AFP). The AFP antibody is highly specific and shows no cross-reaction with other oncofetal antigens or serum albumin. Alpha fetoprotein is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. AFP antibody has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: This antibody recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as Alpha fetoprotein (AFP). The AFP antibody is highly specific and shows no cross-reaction with other oncofetal antigens or serum albumin. Alpha fetoprotein is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. AFP antibody has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Description: This antibody recognizes an oncofetal glycoprotein with a single chain of 70kDa, which is identified as Alpha fetoprotein (AFP). The AFP antibody is highly specific and shows no cross-reaction with other oncofetal antigens or serum albumin. Alpha fetoprotein is normally synthesized in the liver, intestinal tract, and yolk sac of the fetus. AFP antibody has been shown to be useful in detecting hepatocellular carcinomas (HCC) and germ cell neoplasms, especially yolk sac tumors.
Dose-response Affiliation between C-Reactive Protein and Threat of All-Trigger and Trigger-Particular Mortality: A Systematic Evaluation and Meta-Evaluation of Cohort Research
Goal: To quantitatively assess the affiliation between CRP and all-cause, heart problems (CVD), and most cancers mortality, a dose-response meta-analysis was carried out on information from cohort research normally inhabitants.
Strategies: The printed related articles have been looked for in PubMed, Internet of Science, and Embase till September 21, 2019. The pooled relative danger (RR) was estimated by random results of generalized least sq. regression fashions. The dose-response relationship was modeled utilizing restricted cubic splines.
Anti-Alpha Fetoprotein Antibody BIOTIN
Outcomes: Twenty-two articles have been screened for the meta-analysis. In contrast with the low CRP group, the pooled RR within the average CRP group was 1.30 (95% CI, 1.20-1.41) for all-cause mortality, 1.43 (95% CI, 1.22-1.68) for CVD mortality; the pooled RR within the excessive CRP group was 1.75 (95% CI, 1.59-1.92) for all-cause mortality, 2.02 (95% CI, 1.70-2.41) for CVD mortality, and 1.32 (95% CI, 1.21-1.45) for most cancers mortality.
Conclusions: This meta-analysis demonstrated the relationships between CRP and mortality have been nonlinear for all-cause and CVD mortality, and have been linear for most cancers and non-cardiovascular mortality.
Human Alpha Fetoprotein (AFP) ELISA Package, 96 checks, Quantitative
Alcohol abuse is positively related to heart problems. Dietary low-carbohydrate/high-protein (LCHP) consumption confers a better mortality danger.
Right here, the influence of ethanol (Et) consumption together with dietary LCHP consumption on left ventricular (LV) systolic operate and deadly ventricular arrhythmia susceptibility have been investigated in apolipoprotein E/low-density lipoprotein receptor double-knockout (AL) mice.
The underlying mechanisms, cardiac sympathovagal steadiness, beta-adrenergic receptor (ADRB) ranges, and hole junction channel protein connexin 43 (Cx43) expression have been examined. Male AL mice fed an LCHP weight loss program with or with out Et have been bred for 16 weeks.
Age-matched male AL and wild-type mice acquired normal chow weight loss program and served as controls.
The next have been used to evaluate LV systolic operate, deadly ventricular arrhythmia susceptibility, cardiac sympathovagal steadiness, Cx43 expression, and ADRB ranges: echocardiography; electrocardiography and a ventricular arrhythmia-evoked check; LV tyrosine hydroxylase (TH) expression proven by a fluorescence immunohistochemical examination and the ratio of low-frequency energy to high-frequency energy (LF/HF) as indicated by the center fee variability (HRV); Cx43 expression in each a fluorescence immunohistochemical examination and polymerase chain response (PCR); and ADRB1 and ADRB2 expressions in fluorescence immunohistochemical examination.
The outcomes demonstrated that Et consumption together with dietary LCHP consumption worsened LCHP-induced LV systolic dysfunction in AL mice and enhanced their susceptibility within the ventricular arrhythmia-evoked check.
There have been concomitant will increase in LV weight, LF/HF ratio proven by HRV, TH, ADRB1, ADRB2, and Cx43 expressions by LV fluorescence immunohistochemistry, and LV Cx43 messenger ribonucleic acid expression by PCR. In AL mice, alcohol consumption mixed with dietary LCHP consumption could thus promote a shift in cardiac sympathovagal steadiness towards sympathetic predominance, the will increase in beta-adrenergic receptors after which have an effect on the hole junction channel protein Cx43, which in flip may contribute to elevated dangers of LV systolic dysfunction and susceptibility to deadly ventricular arrhythmia.
Description: A polyclonal antibody against ZNF287. Recognizes ZNF287 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody against ZNF287. Recognizes ZNF287 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC;WB:1:500-1:3000, IHC:1:50-1:100
Description: A polyclonal antibody for detection of ZNF287 from Human. This ZNF287 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human ZNF287 at AA range: 210-290
Description: A polyclonal antibody for detection of ZNF287 from Human. This ZNF287 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human ZNF287 at AA range: 210-290
Description: A polyclonal antibody for detection of ZNF287 from Human. This ZNF287 antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human ZNF287 at AA range: 210-290
Description: A polyclonal antibody against ZNF287. Recognizes ZNF287 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA
Description: A polyclonal antibody against ZNF287. Recognizes ZNF287 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA
Description: A polyclonal antibody against ZNF287. Recognizes ZNF287 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA
Ronald
